The latest update is out from Koa Shoji Holdings Co., Ltd. ( (JP:9273) ).
Koa Shoji Holdings Co., Ltd. reported a significant increase in the volume share of generics to 90.1% by October 2024, driven by a selective care system encouraging the use of generic drugs. Despite an interim NHI price revision and minimal impact from U.S. policies, the company saw increased sales and profit in its API and pharmaceutical segments, leading to an improved operating margin and a revised dividend forecast of 16 yen per share.
More about Koa Shoji Holdings Co., Ltd.
Koa Shoji Holdings Co., Ltd. operates in the pharmaceutical industry, focusing on the production and sale of active pharmaceutical ingredients (API) and pharmaceuticals. The company primarily serves the domestic market in Japan.
Average Trading Volume: 85,931
Technical Sentiment Signal: Buy
Current Market Cap: Yen28.77B
Learn more about 9273 stock on TipRanks’ Stock Analysis page.